Paris, France and Camberley, UK – 2 June 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides an update on its polymerase chain reaction (PCR) test for COVID-19, developed by Primerdesign, the Company’s molecular diagnostics division.
http://novacyt.com/wp-content/uploads/2020/06/Novacyt-COVID-19-update-02-06-20-ENGLISH.pdf